|
|
|
Volumn 156, Issue 3, 1996, Pages 1101-1109
|
|
The antitumoral effect of the immunomodulator AS101 and paclitaxel (Taxol) in a murine model of lung adenocarcinoma
a
a
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMMONIUM TRICHLORO(DIOXYETHYLENE O,O')TELLURATE;
DNA FRAGMENT;
NITRIC OXIDE;
NITRIC OXIDE SYNTHASE;
PACLITAXEL;
PROTEIN P53;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CANCER INHIBITION;
CELL CYCLE;
CLONOGENESIS;
CONTROLLED STUDY;
DRUG CYTOTOXICITY;
DRUG MECHANISM;
DRUG POTENTIATION;
DRUG SENSITIVITY;
FEMALE;
IMMUNOMODULATION;
INTRAPERITONEAL DRUG ADMINISTRATION;
LUNG ADENOCARCINOMA;
MALE;
MOUSE;
NONHUMAN;
PERITONEUM MACROPHAGE;
PRIORITY JOURNAL;
SURVIVAL RATE;
ADENOCARCINOMA;
ADJUVANTS, IMMUNOLOGIC;
ANIMALS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CELL CYCLE;
CELL DIVISION;
CYTOTOXICITY, IMMUNOLOGIC;
DISEASE MODELS, ANIMAL;
DRUG THERAPY, COMBINATION;
ETHYLENES;
FEMALE;
LUNG NEOPLASMS;
MACROPHAGE ACTIVATION;
MALE;
MICE;
MICE, INBRED BALB C;
NEOPLASM TRANSPLANTATION;
NITRIC OXIDE;
PACLITAXEL;
TUMOR CELLS, CULTURED;
TUMOR SUPPRESSOR PROTEIN P53;
|
|
EID: 0030064034
PISSN: 00221767
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (27)
|
|
References (0)
|
